Verastem, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for VSTM, updated each market day.
VSTM AI Sentiment
AI sees no strong directional signal for Verastem, Inc. stock over the next 10 market days.
Prediction date: Sept. 22, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Verastem, Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Sector
Exchange
Market Cap
$683,753,979
Cap Tier
Employees
102
Headquarters
NEEDHAM, MA
Listed Since
Jan. 27, 2012
Website
VSTM Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
VSTM Volatility
Verastem, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
